Journal ArticleOPEN ACCESS

Tositumomab and iodine I 131 tositumomab (Bexaar)

American Journal of Neuroradiology (2011) 32(4) 637-638
DOI: 10.3174/ajnr.A2593
21Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

Abstract

Tositumomab and iodine I 131 tositumomab (Bexaar) therapeutic regimen targets monoclonal antibodies against the CD20 antigen expressed in non-Hodgkin lymphoma. This article reviews the mechanism of action and clinical indications for this regimen. Copyright © 2011 by the American Society of Neuroradiology.

Cite

CITATION STYLE

APA

Srinivasan, A., & Mukherji, S. K. (2011). Tositumomab and iodine I 131 tositumomab (Bexaar). American Journal of Neuroradiology, 32(4), 637–638. https://doi.org/10.3174/ajnr.A2593

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free